Arid4a was confirmed to suppress breast tumor metastasis progression by stabilizing the transcripts of tumor metastasis–suppressing genes, suggesting that Arid4a might be a potential therapeutic target for breast cancer treatment. This evidence concerns the gene ARID4A and breast cancer.